4 results match your criteria: "Baylor Scott and White Health Heart Hospital-Plano[Affiliation]"
Olpasiran Pharmacodynamic Study: Ensuring We Go a Mile Deep But More Than an Inch Wide.
J Am Coll Cardiol
August 2024
Center for Cardiovascular Disease Prevention, Baylor Scott and White Health Heart Hospital-Plano, Plano, Texas, USA.
STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
Ann Thorac Surg
February 2021
Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
The STS-ACC TVT Registry (Society of Thoracic Surgeons-American College of Cardiology Transcatheter Valve Therapy Registry) from 2011 to 2019 has collected data on 276,316 patients undergoing transcatheter aortic valve replacement (TAVR) at sites in all U.S. states.
View Article and Find Full Text PDFSTS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.
J Am Coll Cardiol
November 2020
Division of Cardiovascular Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
The STS-ACC TVT Registry (Society of Thoracic Surgeons-American College of Cardiology Transcatheter Valve Therapy Registry) from 2011 to 2019 has collected data on 276,316 patients undergoing transcatheter aortic valve replacement (TAVR) at sites in all U.S. states.
View Article and Find Full Text PDFBicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement.
J Am Coll Cardiol
September 2020
Cedars-Sinai Medical Center, Smidt Cedars-Sinai Heart Institute, Los Angeles, California. Electronic address:
Background: Bicuspid aortic stenosis accounts for almost 50% of patients undergoing surgical aortic valve replacement in the younger patients. Expanding the indication of transcatheter aortic valve replacement (TAVR) toward lower-risk and younger populations will lead to increased use of TAVR for patients with bicuspid aortic valve (BAV) stenosis despite the exclusion of bicuspid anatomy in all pivotal clinical trials.
Objectives: This study sought to evaluate the association of BAV morphology and outcomes of TAVR with the new-generation devices.